Search

Search Constraints

You searched for: Author/Creator Soo, Ross

Search Results

1. 387 A Phase II, multicenter study of the safety and efficacy of LAG525 in combination with spartalizumab in patients with advanced malignancies. (9th November 2020)

2. A phase 1 study of the safety, pharmacokinetics and pharmacodynamics of escalating doses followed by dose expansion of the selective inhibitor of nuclear export (SINE) selinexor in Asian patients with advanced or metastatic malignancies. (March 2022)

5. Global named patient use program of afatinib in advanced non-small-cell lung carcinoma patients who progressed following prior therapies. (June 2018)

6. Low‐dose pembrolizumab in the treatment of advanced non‐small cell lung cancer. Issue 1 (6th March 2021)

7. The prevalence of expression of MAGE-A3 and PRAME tumor antigens in East and South East Asian non-small cell lung cancer patients. (November 2016)

8. The prevalence of expression of MAGE-A3 and PRAME tumor antigens in East and South East Asian non-small cell lung cancer patients. (November 2016)